Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

  • This share is currently suspended. It was suspended at a price of 130.00
  • There is currently no data for DLAR

Pre-Close Trading Statement

17 Apr 2024 07:00

RNS Number : 8541K
De La Rue PLC
17 April 2024
 

 

17 April 2024 

De La Rue plc

Pre-close trading update

De La Rue plc ("De La Rue", the "Group" or the "Company") today gives a trading update for the financial year ended 30 March 2024 ("FY24").

For FY24, the Group expects adjusted operating profit to be in line with guidance previously given, in the low £20m range. Net debt is expected to be around £90m, which is marginally better than previous guidance. In addition, the Authentication division is expected to report revenue in excess of £100m, as previously targeted.

The Group's results for the period ended 30 March 2024 will be announced on 18 June 2024.

As previously noted, the Board intends to provide an update by 31 May 2024 on progress in optimising the underlying intrinsic value of the business for the benefit of all stakeholders.

 

Enquiries

 

De La Rue plc

+44 (0)7990 337707

Clive Vacher

Chief Executive Officer

Dean Moore

Interim Chief Financial Officer

Louise Rich

Head of Investor Relations

Brunswick

+44 (0)207 404 5959

Stuart Donnelly

Ed Brown

 

About De La Rue

Established over 210 years ago, De La Rue is trusted by governments, central banks, and international brands, providing digital and physical solutions that protect their supply chains and cash cycles from counterfeiting and illicit trade.

With operations in five continents, customers in 140 countries and solutions that include advanced track and trace software, security document design, banknotes, brand protection labels, tax stamps, security features and passport bio-data pages, De La Rue brings unparalleled knowledge and expertise to its partnerships and projects.

Our core focus areas are:

- Authentication: leveraging advanced digital software solutions and security labels to protect revenues and reputations from the impacts of illicit trade, counterfeiting, and identity theft.

- Currency: designing and manufacturing highly secure banknotes and banknote components that are optimised for security, manufacturability, cash cycle efficacy and public engagement.

The security and trust derived from our solutions pave the way for robust economies and flourishing societies. This is underpinned by a significant Environmental, Social, and Governance commitment that is evidenced by accolades such as the ISO 14001 certification and a consistent ranking in the top tier of the Financial Times European Climate Leaders list.

De La Rue's shares are traded on the London Stock Exchange (LSE: DLAR). De La Rue plc's LEI code is 213800DH741LZWIJXP78. For further information please visit www.delarue.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTIFMATMTBBBJI
Date   Source Headline
4th Feb 20198:00 amRNSAdditional Listing
31st Jan 20194:47 pmRNSTotal Voting Rights
14th Jan 20192:20 pmEQSEdison issues initiation on De La Rue (DLAR)
8th Jan 20199:00 amRNSAdditional Listing
7th Jan 201912:01 pmRNSDe La Rue PLC - Director/PDMR Shareholding
2nd Jan 201911:10 amRNSBlock listing Interim Review
31st Dec 201812:53 pmRNSHolding(s) in Company
31st Dec 201812:44 pmRNSTotal Voting Rights
19th Dec 20185:02 pmRNSDirector/PDMR Shareholding
14th Dec 20184:44 pmRNSDirector/PDMR Shareholding
30th Nov 20184:57 pmRNSTotal Voting Rights
27th Nov 20187:00 amRNS2018/19 HALF YEAR RESULTS AND STRATEGY UPDATE
6th Nov 20181:08 pmRNSNotice of Half Year Results
31st Oct 20184:43 pmRNSTotal Voting Rights
9th Oct 201810:00 amRNSAdditional Listing
1st Oct 20185:30 pmRNSTotal Voting Rights
10th Sep 20181:32 pmRNSHolding(s) in Company
31st Aug 20184:54 pmRNSTotal Voting Rights
29th Aug 201812:22 pmRNSDirector/PDMR Shareholding
22nd Aug 20184:12 pmRNSHolding(s) in Company
17th Aug 20185:23 pmRNSHolding(s) in Company
16th Aug 20189:30 amRNSAdditional Listing
3rd Aug 20189:27 amRNSDirector/PDMR Shareholding
3rd Aug 20189:00 amRNSAdditional Listing
31st Jul 20184:45 pmRNSTotal Voting Rights
26th Jul 20182:35 pmRNSResult of AGM
26th Jul 201810:30 amRNSAGM Statement
25th Jul 20185:21 pmRNSHolding(s) in Company
25th Jul 20187:00 amRNSHolding(s) in Company
19th Jul 20187:00 amRNSDirectorate Change
13th Jul 20185:56 pmRNSDirector/PDMR Shareholding
13th Jul 20185:54 pmRNSDirector/PDMR Shareholding
3rd Jul 201811:41 amRNSDirector/PDMR Shareholding
2nd Jul 20181:57 pmRNSBlock Listing Six Monthly Return
2nd Jul 201812:01 pmRNSTotal Voting Rights
27th Jun 201812:59 pmRNSDirector/PDMR Shareholding
21st Jun 20184:14 pmRNSAnnual Financial Report
19th Jun 20185:40 pmRNSDirector/PDMR Shareholding
14th Jun 20182:25 pmRNSDirector/PDMR Shareholding
12th Jun 20184:04 pmRNSDirector/PDMR Shareholding
4th Jun 20185:25 pmRNSDirector/PDMR Shareholding
31st May 20185:35 pmRNSTotal Voting Rights
30th May 20187:00 amRNS2017/18 FULL YEAR RESULTS
23rd May 20189:38 amRNSNotice of Full Year Results
30th Apr 20183:48 pmRNSTotal Voting Rights
30th Apr 20182:44 pmRNSHolding(s) in Company
18th Apr 20187:00 amRNSUpdate on full year outturn & UK passport tender
9th Apr 20185:27 pmRNSHolding(s) in Company
3rd Apr 201810:44 amRNSTotal Voting Rights
29th Mar 20183:19 pmRNSCompletion of paper transaction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.